News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
697,240 Results
Type
Article (66058)
Company Profile (215)
Press Release (630956)
Multimedia
Podcasts (123)
Webinars (23)
Section
Business (181334)
Career Advice (2822)
Deals (33762)
Drug Delivery (130)
Drug Development (79935)
Employer Resources (156)
FDA (15792)
Job Trends (14819)
News (318687)
Policy (31184)
Tag
2027 BioMidwest Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (2)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (2967)
Academic (2)
Accelerated approval (39)
Adcomms (30)
Allergies (156)
Alliances (45489)
ALS (178)
Alzheimer's disease (1673)
Antibody-drug conjugate (ADC) (324)
Approvals (16076)
Artificial intelligence (577)
Autoimmune disease (178)
Automation (46)
Bankruptcy (299)
Best Places to Work (11672)
BIOSECURE Act (19)
Biosimilars (195)
Biotechnology (150)
Bladder cancer (165)
Brain cancer (66)
Breast cancer (649)
Cancer (4988)
Cardiovascular disease (426)
Career advice (2414)
Career pathing (41)
CAR-T (298)
CDC (55)
Celiac Disease (2)
Cell therapy (797)
Cervical cancer (37)
Clinical research (68462)
Collaboration (1795)
Company closure (5)
Compensation (871)
Complete response letters (65)
COVID-19 (2796)
CRISPR (103)
C-suite (950)
Cystic fibrosis (154)
Data (6495)
Decentralized trials (2)
Denatured (48)
Depression (143)
Diabetes (516)
Diagnostics (6716)
Digital health (47)
Diversity (13)
Diversity, equity & inclusion (40)
Drug discovery (280)
Drug pricing (202)
Drug shortages (29)
Duchenne muscular dystrophy (227)
Earnings (67496)
Editorial (65)
Employer branding (18)
Employer resources (140)
Events (105825)
Executive appointments (1057)
FDA (19050)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (11)
Frontotemporal dementia (25)
Funding (1538)
Gene editing (217)
Generative AI (52)
Gene therapy (637)
GLP-1 (1030)
Government (4936)
Grass and pollen (8)
Guidances (384)
Healthcare (19157)
HIV (70)
Huntington's disease (44)
IgA nephropathy (84)
Immunology and inflammation (244)
Immuno-oncology (67)
Indications (127)
Infectious disease (3082)
Inflammatory bowel disease (205)
Inflation Reduction Act (13)
Influenza (124)
Intellectual property (259)
Interviews (541)
IPO (15695)
IRA (50)
Job creations (3535)
Job search strategy (2000)
JPM (65)
Kidney cancer (19)
Labor market (79)
Layoffs (606)
Leadership (40)
Legal (7002)
Liver cancer (90)
Longevity (16)
Lung cancer (665)
Lymphoma (380)
Machine learning (46)
Management (55)
Manufacturing (828)
MASH (168)
Medical device (13277)
Medtech (13336)
Mergers & acquisitions (19240)
Metabolic disorders (1322)
mRNA (176)
Multiple sclerosis (166)
NASH (17)
Neurodegenerative disease (332)
Neuropsychiatric disorders (93)
Neuroscience (2958)
Neurotech (1)
NextGen: Class of 2026 (6706)
Non-profit (4627)
Now hiring (31)
Obesity (622)
Opinion (315)
Ovarian cancer (166)
Pain (216)
Pancreatic cancer (238)
Parkinson's disease (288)
Partnered (33)
Patents (522)
Patient recruitment (541)
Peanut (64)
People (62137)
Pharmaceutical (43)
Pharmacy benefit managers (29)
Phase 1 (21387)
Phase 2 (29997)
Phase 3 (22322)
Pipeline (5811)
Policy (307)
Postmarket research (2713)
Preclinical (9153)
Press Release (67)
Prostate cancer (266)
Psychedelics (47)
Radiopharmaceuticals (304)
Rare diseases (914)
Real estate (6177)
Recruiting (67)
Regulatory (23901)
Reports (41)
Research institute (2563)
Resumes & cover letters (419)
Rett syndrome (30)
RNA editing (18)
RSV (77)
Schizophrenia (153)
Series A (258)
Series B (193)
Service/supplier (8)
Sickle cell disease (104)
Special edition (21)
Spinal muscular atrophy (164)
Sponsored (44)
Startups (3519)
State (1)
Stomach cancer (14)
Supply chain (95)
Tariffs (84)
The Weekly (73)
Vaccines (1036)
Venture capital (89)
Weight loss (399)
Women's health (95)
Worklife (22)
Date
Today (147)
Last 7 days (862)
Last 30 days (2740)
Last 365 days (29676)
2026 (4979)
2025 (29857)
2024 (33988)
2023 (38206)
2022 (48769)
2021 (53618)
2020 (52630)
2019 (46536)
2018 (35417)
2017 (31979)
2016 (31462)
2015 (36830)
2014 (29666)
2013 (26261)
2012 (27563)
2011 (27731)
2010 (26025)
Location
Africa (943)
Alabama (90)
Alaska (6)
Arizona (253)
Arkansas (15)
Asia (41621)
Australia (7340)
California (11059)
Canada (3218)
China (1135)
Colorado (458)
Connecticut (485)
Delaware (337)
Europe (96382)
Florida (1693)
Georgia (375)
Hawaii (3)
Idaho (61)
Illinois (941)
India (72)
Indiana (543)
Iowa (22)
Japan (450)
Kansas (121)
Kentucky (42)
Louisiana (29)
Maine (75)
Maryland (1339)
Massachusetts (8008)
Michigan (346)
Minnesota (572)
Mississippi (7)
Missouri (138)
Montana (35)
Nebraska (27)
Nevada (119)
New Hampshire (79)
New Jersey (3075)
New Mexico (30)
New York (2989)
North Carolina (1501)
North Dakota (10)
Northern California (5356)
Ohio (334)
Oklahoma (23)
Oregon (44)
Pennsylvania (2200)
Puerto Rico (24)
Rhode Island (46)
South America (1243)
South Carolina (55)
South Dakota (1)
Southern California (4372)
Tennessee (173)
Texas (1759)
United States (39816)
Utah (347)
Vermont (1)
Virginia (275)
Washington D.C. (77)
Washington State (937)
West Virginia (4)
Wisconsin (130)
Wyoming (2)
697,240 Results for "stanford university school of medicine".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Cellares and University of Wisconsin School of Medicine and Public Health Expand Partnership to Clinical Manufacturing of CRISPR-Edited CAR-T for Solid Tumors
February 18, 2026
·
4 min read
Press Releases
Stellaromics Expands Pyxa™ 3D Spatial Transcriptomics Beta Program with Installation at Emory University School of Medicine
January 29, 2026
·
3 min read
Press Releases
Cocrystal Pharma Receives IRB Approval from Emory University School of Medicine for Phase 1b Human Challenge Study with CDI-988 for Prevention and Treatment of Norovirus
December 19, 2025
·
7 min read
Opinion
2026 Could Mark a Turning Point for American Innovation
The current state of political affairs in the U.S. does not bode well for the direction of that turn. The country is at real risk of losing its long-held lead in biotech innovation.
February 16, 2026
·
4 min read
·
John Stanford
Business
Novocure and Stanford School of Medicine to Establish Tumor Treating Fields Research Program
Novocure (NASDAQ: NVCR) today announced it has entered into an agreement with Stanford University to establish the Stanford School of Medicine Tumor Treating Fields (TTFields) Research Program.
October 12, 2023
·
5 min read
Press Releases
Comphya Announces First Patient Implanted with CaverSTIM in U.S. Pilot Study at Johns Hopkins University School of Medicine
October 1, 2025
·
4 min read
Regulatory
FDA’s CDER Gets New Chief in Biopharma Veteran George Tidmarsh
Tidmarsh, an adjunct professor at Stanford’s medical school, brings decades of industry experience to the table. Serving as director of the Center for Drug Evaluation and Research will be his first government position.
July 21, 2025
·
2 min read
·
Dan Samorodnitsky
Press Releases
NorthStar Medical Radioisotopes, LLC and University of Wisconsin School of Medicine and Public Health Enter Strategic Partnership to Advance Radiopharmaceutical Research, Innovation and Talent Development
September 24, 2025
·
4 min read
Press Releases
DISTINGUISHED CANCER RESEARCHER STUART S. MARTIN, PHD, NAMED CHAIR OF THE DEPARTMENT OF PHARMACOLOGY & PHYSIOLOGY AT UM SCHOOL OF MEDICINE
November 11, 2025
·
7 min read
Press Releases
Model Medicines Unveils Groundbreaking Preclinical Data: Oral MDL-001 Demonstrates Superiority or Equivalence to Three Standard-of-Care Antivirals: Nirmatrelvir, Remdesivir, and Sofosbuvir, Across Respiratory and Hepatic Viral Diseases
Oral MDL-001 Demonstrated Equivalence to Remdesivir and Sofosbuvir in Head-to-Head Animal Model Studies Performed at The Icahn School of Medicine at Mount Sinai and Scripps Research, and Superiority to Nirmatrelvir in a Literature Comparison of Equivalent Animal Models. The Potential First-in-Category, Direct-Acting, Broad-Spectrum Antiviral Targets A Novel Conserved Site on The Viral Polymerase Across Six Viral Families.
December 4, 2025
·
1 min read
1 of 69,724
Next
